Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05809115 · ClinicalTrials.gov registry record
Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story
A clinical trial of Depression and Anxiety, sponsored by Baylor College of Medicine.
- Active
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT05809115 is a study of Depression and Anxiety that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 2,000 participants, above the 783-participant average among 679 other Depression trials with a reported enrollment target (155% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05809115, a study of Depression and Anxiety, is active but no longer recruiting, sponsored by Baylor College of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The main goal of this research is to help families who are experiencing food insecurity (FI) and help mothers with depression. The next goal is to provide other resources to help with household needs like rent or utility assistance, health insurance, anxiety, and depression. Our theory is that helping with food insecurity, household needs, and emotional health will help children and families.
Conditions Studied
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2023-06-14 |
| Est. Completion | 2026-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05809115
The ClinicalTrials.gov registry entry for NCT05809115 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 783-participant average among 679 other Depression trials with a reported enrollment target (155% higher). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 0 interventions.
NCT05809115 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05809115 about?
NCT05809115 is a clinical study titled "Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story". The main goal of this research is to help families who are experiencing food insecurity (FI) and help mothers with depression. The next goal is to provide other resources to help with household needs like rent or utility assistance, health insurance, anxiety, and depression. Our theory is that help...
What is the current status of trial NCT05809115?
This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2023-06-14. Estimated completion is 2026-03.
What conditions does trial NCT05809115 study?
This clinical trial studies the following conditions: Depression, Anxiety, Food Insecurity.
Who is sponsoring clinical trial NCT05809115?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05809115 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.